Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,4695 USD | +3,01% | +7,81% | -18,35% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 9,04 mln. 8,46 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -4 mln. -3,74 mln. | Nettowinst (verlies) 2025 * | -13 mln. -12,16 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,76
x | K/w-verhouding 2025 * |
-1,57
x | Werknemers | 4 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,29% |
Recentste transcriptie over Virios Therapeutics, Inc.
1 dag | +3,01% | ||
1 week | +7,81% | ||
Lopende maand | -2,00% | ||
1 maand | +9,16% | ||
3 maanden | +14,51% | ||
6 maanden | -8,87% | ||
Lopend jaar | -18,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 01-04-20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 21-12-20 |
Richard Whitley
BRD | Director/Board Member | 78 | 21-12-20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,4695 | +3,01% | 40 647 |
25-04-24 | 0,4558 | +7,20% | 64 289 |
24-04-24 | 0,4252 | -1,35% | 200 892 |
23-04-24 | 0,431 | +1,25% | 78 947 |
22-04-24 | 0,4257 | -2,25% | 72 087 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,35% | 9,04 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |